Speaker illustration

Professor Andrew H Baker

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Andrew graduated from the University of London in 1990 with a First Class BSc (Joint Honours) in pharmacology and toxicology and then studied for his PhD with the Leukaemia Research Fund at the University of Wales College Of Medicine, graduating in 1994. He then joined the group led by Professor Andrew Newby for his post-doctoral work in Cardiff He then transferred to a lectureship at the University of Bristol (Bristol Heart Institute) to continue studies on adenovirus-mediated gene transfer to assess vascular function and gene therapy. In 1999, Dr. Baker joined Professor Anna Dominiczak at the University of Glasgow as a Senior Lecturer in Molecular Medicine, then as Reader and in 2005 as Professor of Molecular Medicine. From 1st October, 2015 Andrew relocated his BHF Chair to the Centre for Cardiovascular Science at the Queen’s Medical Research Institute, University of Edinburgh, UK. He became Head of Cardiovascular Science June 2017.

Targeting acute vessel wall remodelling with novel non-coding RNA approaches.

Event: ESC Congress 2022

Topic: Basic Science

Session: New frontiers of discovery in cardiovascular research


Function of non-coding RNA in the vascular endothelium

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Biomarkers

Session: Biomarkers in arterial thrombosis


Targeting long non-coding RNAs in cardiovascular disease.

Event: ESC Congress 2020

Topic: Basic Science

Session: The RNA Frontier: Close to Therapeutic Applications?


ESC 365 is supported by

logo Novo Nordisk